Thrombolysis in acute cerebrovascular disease: indications and limitations.
作者信息
Hacke W, Ringleb P, Stingele R
机构信息
Department of Neurology, Ruprecht-Karls-Universitat Heidelberg, Germany.
出版信息
Thromb Haemost. 1999 Aug;82(2):983-6.
PMID:10605813
Abstract
摘要
相似文献
1
Thrombolysis in acute cerebrovascular disease: indications and limitations.
Thromb Haemost. 1999 Aug;82(2):983-6.
2
The results of arterial thrombolysis.
Ann Chir Gynaecol. 1995;84(4):350-3.
3
Thrombolysis: the elusive El-Dorado.
J Assoc Physicians India. 2007 Dec;55:874-5.
4
Criteria for selection of older patients for thrombolytic therapy.
Clin Geriatr Med. 1999 Nov;15(4):721-39.
5
Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain.
Acad Emerg Med. 2005 Apr;12(4):348-51. doi: 10.1197/j.aem.2004.10.027.
6
Predicted impact of intravenous thrombolysis. Another trial is needed.
BMJ. 2000 Apr 8;320(7240):1007.
7
[Thrombolytic therapy for acute ischemic stroke].
Nihon Rinsho. 2006 Nov 28;64 Suppl 8:33-7.
8
The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
J Emerg Med. 2005 Oct;29(3):273-7. doi: 10.1016/j.jemermed.2005.05.001.
9
[Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
Ital Heart J Suppl. 2000 Jul;1(7):947-8.
10
Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism.
Am J Emerg Med. 2011 Oct;29(8):961.e1-4. doi: 10.1016/j.ajem.2010.08.020. Epub 2010 Oct 27.
引用本文的文献
1
[Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis].
Nervenarzt. 2006 Feb;77(2):215-20. doi: 10.1007/s00115-005-1988-4.
2
S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion.
J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):322-5. doi: 10.1136/jnnp.74.3.322.
Zotero 插件